Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cosmesis in segmental mastectomy

R G Margolese

    Canadian Journal of Surgery. Journal Canadien De Chirurgie
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Properly designed clinical trials are essential for determining the best primary breast cancer treatment. Experience with segmental mastectomy shows technical improvements can achieve adequate cancer removal with good cosmetic outcomes, encouraging trial participation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
    Same author

    Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Ambulatory surgery for breast cancer patients.

    Annals of surgical oncology·2000
    Same author

    Surgical considerations for invasive breast cancer.

    The Surgical clinics of North America·1999
    Same author

    Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

    Lancet (London, England)·1999
    Same author

    Surgical considerations in preoperative chemotherapy of breast cancer.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·1999

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Breast Cancer Research

    Background:

    • The optimal treatment for primary breast cancer remains debated, pending results from well-designed clinical trials.
    • Surgeons' reluctance to participate stems from concerns about achieving adequate cancer resection while preserving breast aesthetics.
    • Poor cosmetic outcomes are often attributed to limited experience with segmental mastectomy techniques.

    Purpose of the Study:

    • To address the controversy surrounding primary breast cancer treatment by evaluating surgical techniques.
    • To identify causes of cosmetic failure in breast cancer surgery and propose solutions.
    • To encourage surgeon and patient participation in clinical trials for breast cancer surgery.

    Main Methods:

    • Analysis of experience with 400 patients within the National Surgical Adjuvant Breast Project (NSABP) protocol.

    Related Experiment Videos

  • Identification of technical aspects crucial for wide local excision with minimal cosmetic compromise.
  • Review of factors contributing to suboptimal cosmetic results in segmental mastectomy.

    • Main Results:

    • Technical refinements enable wide local excision of breast cancer with improved cosmetic preservation.
    • Experience demonstrates that segmental mastectomy can yield satisfactory aesthetic results.
    • Understanding the causes of cosmetic failure allows for the implementation of corrective measures.

    Conclusions:

    • Improved surgical techniques can overcome cosmetic challenges in breast cancer treatment.
    • Successful cosmetic outcomes in segmental mastectomy can encourage participation in clinical trials.
    • Further clinical trials are needed to definitively establish the best treatment for primary breast cancer.